Lead Pharma Holding B.V.

https://www.leadpharma.com

Lead Pharma is a pharmaceutical company focusing on the discovery and development of innovative medicines for the treatment of immune diseases and cancer. Lead Pharma is headquartered at Pivot Park, the biopharmaceutical life sciences campus in Oss, the Netherlands. We have fully equipped labs for all stages of drug discovery, including medicinal chemistry, cellular pharmacology, and molecular pharmacology, as well as an “in silico” lab for our computational chemistry, bioinformatics, and data mining activities. Lead Pharma has a qualified team of 29 people of which 10 hold a PhD degree and have long term experience working in large pharmaceutical companies, biotech companies and academia. *

	Start	2015-02-18 existent
	Industry	ROR gamma inhibitor (orphan nuclear receptor gamma inhibitor)
	Industry 2	small-molecule drug
	Person	van den Berg, Frans (Lead Pharma 202011 CEO)
	Person 2	Oubrie, Arthur (Lead Pharma 201502 CSO)

	Region	Oss
	Country	Netherlands
	Street	9 Kloosterstraat Pivot Park, RK Building
	City	5349 AB Oss
	Tel	+31-412-782999
		Address record changed: 2020-12-02

Basic data	Employees	n. a.

		* Document for »About Section«: Lead Pharma Holding B.V.. (11/16/20). "Press Release: Lead Pharma Enters into a Research Collaboration and License Agreement with Roche to Develop Oral Small Molecules for Immune Mediated Diseases".

		Record changed: 2025-03-16

Picture Consultech GmbH Secure Funding with RnD Grants 650x200px

More documents for Lead Pharma Holding B.V.

[1] Lead Pharma Holding B.V.. (11/16/20). "Press Release: Lead Pharma Enters into a Research Collaboration and License Agreement with Roche to Develop Oral Small Molecules for Immune Mediated Diseases"....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]